OVID Price Chart
Loading chart...
50 DMA150 DMA200 DMA
OVIDOvid Therapeutics Inc.
$1.65
Financials
NEUTRAL
Investment Thesis
OVID is neither a clear buy nor avoid. RS 96/99, moderate earnings. keep it on your radar.
Mixed signals = No edge currently
Key Takeaways
- Earnings moderate
- RS 96 (Top 4%)
- No base pattern
- Wait & watch
Earnings Momentum
Earnings Declining
Price Structure
Aligned UptrendPrice
$1.65
✓→
50 DMA
$1.54
✓→
100 DMA
$1.48
✓→
150 DMA
$1.16
✓→
200 DMA
$0.94
Alignment Score: 4/4✓ Confirmed Uptrend
Why Not BUY Yet?
EPS Growth
15%→>25% (Strong) or 40%+ (Elite)
Pattern
No base forming→VCP or constructive base
Entry Point
Broke out 5mo ago, now +147%→Wait for pullback or new base
What Would Change Our Mind?
To turn bullish on OVID, we need:
- EPS Growth: >25% (Strong) or 40%+ (Elite)(currently 15%)
- Pattern: VCP or constructive base(currently No base forming)
- Entry Point: Wait for pullback or new base(currently Broke out 5mo ago, now +147%)
- Fresh Entry: Pullback to 50 DMA or new base formation(currently Extended +147% from 5mo ago breakout)
Twin Engines Dashboard
Technical Health
RS Rating
96/99
Top 4% ✓
Trend
Aligned Uptrend
Above 200 DMA
RSI (14)
50
NEUTRAL
VCP Setup
COOL
Score: 5/9
Volume
709K
-55% vs avg
From Entry
+146.7%
$0.67
Fundamental Horsepower
EPS Qtr YoY
+15%
Accelerating
EPS 3Y CAGR
N/A
Annual Earnings
Revenue Qtr
-24%
DECLINING
F-Score
2/9
Piotroski Quality
ROE
-34%
Return on Equity
EPS Rank
38/99
Percentile
Trade Plan
Lost MomentumBreakout Date2025-07-22177 days ago
Entry Was$0.67Breakout price
Gain Since+147%From entry
Reclaim$1.6621 EMA support
If/Then Playbook
IF: RS Rating improves to >80
THEN: Re-evaluate for potential
IF: EPS growth accelerates next quarter
THEN: Check for developing setup
IF: VCP pattern begins forming
THEN: Add to watchlist if RS also improving
IF: Price breaks below 200 DMA
THEN: Remove from radar
Key Price Levels
Resistance
- 20 DMA$1.66+0.7%
- 52W High$2.01+21.8%
Current$1.65
Support
- 50 DMA$1.54-6.4%
- 200 DMA$0.94-42.9%
- 52W Low$0.24-85.3%
More OVID Analysis
Frequently Asked Questions
Is OVID stock a buy now?
OVID is neither a clear buy nor avoid. RS 96/99, moderate earnings. keep it on your radar.
What is the buy point for OVID?
OVID broke out at $0.67 5 month(s) ago and is now +147% extended. Wait for a pullback to the 21 EMA or a new base pattern.
What is OVID's RS Rating?
OVID has an RS Rating of 96/99, meaning it's in the Top 4% of all stocks for relative price performance over the past 12 months. Minervini recommends RS 80+ for momentum trades.
Important Disclosure: This analysis is for educational and informational purposes only. Technical and fundamental indicators are based on historical data and do not guarantee future performance. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.